Potential role of immunotherapy for advanced breast cancer
dc.creator | De Mello R.A., Amaral G.A., Tajima C.C., Tadokoro H., Iavelberg J., Simonetti D., Tolia M., Silva J.A. | en |
dc.date.accessioned | 2023-01-31T07:52:04Z | |
dc.date.available | 2023-01-31T07:52:04Z | |
dc.date.issued | 2021 | |
dc.identifier | 10.2217/imt-2021-0037 | |
dc.identifier.issn | 1750743X | |
dc.identifier.uri | http://hdl.handle.net/11615/73140 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | Immunotherapy | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105502258&doi=10.2217%2fimt-2021-0037&partnerID=40&md5=41be46d663314ab164ae03ccf994c84a | |
dc.subject | atezolizumab | en |
dc.subject | cancer antibody | en |
dc.subject | cancer vaccine | en |
dc.subject | pembrolizumab | en |
dc.subject | phage display vaccine | en |
dc.subject | programmed death 1 receptor | en |
dc.subject | unclassified drug | en |
dc.subject | immunological antineoplastic agent | en |
dc.subject | advanced cancer | en |
dc.subject | antigen recognition | en |
dc.subject | antineoplastic activity | en |
dc.subject | apoptosis | en |
dc.subject | breast cancer | en |
dc.subject | cancer immunotherapy | en |
dc.subject | cancer survival | en |
dc.subject | chimeric antigen receptor T-cell immunotherapy | en |
dc.subject | cytokine production | en |
dc.subject | dendritic cell | en |
dc.subject | disease free survival | en |
dc.subject | human | en |
dc.subject | human epidermal growth factor receptor 2 positive breast cancer | en |
dc.subject | immune response | en |
dc.subject | immunogenicity | en |
dc.subject | nonhuman | en |
dc.subject | Note | en |
dc.subject | overall survival | en |
dc.subject | priority journal | en |
dc.subject | progression free survival | en |
dc.subject | T lymphocyte activation | en |
dc.subject | triple negative breast cancer | en |
dc.subject | tumor escape | en |
dc.subject | tumor microenvironment | en |
dc.subject | breast tumor | en |
dc.subject | female | en |
dc.subject | immunotherapy | en |
dc.subject | procedures | en |
dc.subject | Antineoplastic Agents, Immunological | en |
dc.subject | Breast Neoplasms | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Immunotherapy | en |
dc.subject | Future Medicine Ltd. | en |
dc.title | Potential role of immunotherapy for advanced breast cancer | en |
dc.type | other | en |
Dateien zu dieser Ressource
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |